If you are a Type II diabetes pa ent with POOR SUGAR CONTROL

Your doctor either

Increases doses of your on going medicines OR

Adds new anti-diabetic medicines

Both these options may lower sugar levels

but increase side effects

It is possible to improve Sugar control

without side effects

A Natural, Tried and Tested Anti-diabetic is available

 Private Limited

Presenting
TM

DiaBetes Control

A Formulation with 5 proven anti-diabetic botanicals
 TM
Private Limited

DiaBetes Control

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 TM
Private Limited

DiaBetes Control

Ingredients

Gymnema sylvestre (Madhunashini)

Pterocarpus marsupium (Asana)

Emblica officinalis (Amalaki)

Enicostemma li orale (Mamijva)

Syzygium cumini (Jambu)

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 TM
Private Limited

DiaBetes Control

DBC-24 effectively
Increases secretion of insulin from the islet cells of Pancreas

Promotes regeneration of Pancreatic islet cells

Increases glucose utilization by increasing the enzymatic

activities

Reduces intestinal glucose absorption

Helps production of insulin

Converts of pro- insulin to insulin for cellular glucose uptake

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 TM
Private Limited

DiaBetes Control

Uses of DBC-24
Has anti-diabetic, anti-oxidant, hypolipidaemic and
anti-atherosclerotic properties

Immensely benefits in Type 2 diabetes with proven

hypoglycemic, hypolipidaemic and anti-oxidant actions

Helps regenerate pancreatic beta cellsmblica officinalis

Possesses proven antioxidant property and Enhances glucose

Rx induced insulin release
For newly diagnosed Type 2 Diabetes or
an add-on with OHA's stabilized Type 2 Diabetes

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 C
INI AL

CL
TM

LY
Private Limited

DiaBetes Control

Clinically tested in Type 2 Diabetic Patients*
Clinical trial
“A Randomized, Double Blind, Placebo Controlled, Phase 2, Clinical Study to Evaluate the Efficacy and Safety of
'TLPL/AY/04/2008' (DBC- 24 Tablet) as an Add-on therapy with Oral Hypoglycemic agents (OHA) in Type 2 Diabetic
Patients”.
Results Reveal Significant reduction in Fasting Blood and Post prandial Sugar Levels
in Group A (DBC Group)*

Effect of Trial Drugs on Mean Fasting Blood Sugar Level Group A

Mean Fasting Blood Sugar Value (mg/dl)

Group B
180
164.52
160 158.83
159.98
149.82 144.79

Mean Serum Insulin Level

147.56
140 142.64
135.14

120

100

80

60

40

20

0
Day 0 Day 30 Day 60 Day 90
Treatment Duration in Days

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 4 brings nt
DBC-2 significa
TM
proven and
Clinically s u gar levels ity
Private Limited io n in
reduct Sensitiv
c r e a s e in Insulin
in

DiaBetes Control

Clinically tested in Type 2 Diabetic Patients*
Effect of trial drugs on mean glycosylated Effect of trial drugs on mean serum insulin level*
hemoglobin (HbA1c %)*
Group A
Effect of Trial Drugs on Mean Fasting Blood Sugar Level Group A
Group B Effect of Trial Drugs on Mean Glycosylated Hemoglobin % Group B
Mean Fasting Blood Sugar Value (mg/dl)

180 9.2
164.52

Mean Glycosylated Hemoglobin %

160 158.83
9
159.98 8.94
149.82 147.56 144.79
140 8.8
135.14 142.64

120 8.6
8.49
100 8.4

8.2
80 8.16
8 7.98
60
7.8
40
7.6
20
7.4
0
Day 0 Day 90
Day 0 Day 30 Day 60 Day 90
Treatment Duration in Days Treatment Duration in Days

Significant and Safe Control Within 90 days*

ü 13.3% reduction in mean fasting blood sugar level. ü Mean postprandial blood sugar level reduced from baseline value to 12.87%.
ü Mean serum insulin level reduced from baseline value to 10.2%. ü Excellent Safety * Data on file

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 TM
Private Limited

DiaBetes Control

Dosage:
1 to 2 tablets twice daily orally
with water ½ an hour before meals
or as directed by the Health care professional.

Storage:
Keep container tightly closed. Store in a cool
and dry place, away from direct sunlight.

+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com

 Private Limited

TM

DiaBetes Control

“A Herbal Product by TULIP LAB”

Our Accreditations
+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com
 TM
Private Limited

DiaBetes Control

End user / Distributor / Importers / Exporters /

Contact manufacturing /
End to End Product development
+91-22-66884949 +91 – 9167770808 www.tuliplab.com info@tuliplab.com
 WE ARE GLOBAL
Private Limited CARE BEYOND BOUNDARIES
REGISTERED / PRESENCE UNDER PROCESS

RUSSIA

KAZAKHSTAN

USA UKRAINE
TAZIKISTAN
MOLDOVA
KYRGYZSTAN

ALGERIA
GEORGIA
UZBEKISTAN MYANMAR
INDIA VIETNAM
YEMEN
PHILIPPINIES
COSTA RICA

UGANDA

MALAYSIA

MAURITIUS

SOUTH AFRICA

UKRAINE GEORGIA USA MALAYSIA YEMEN

KAZAKHSTAN KYRGYZSTAN COSTA RICA PHILIPPINIES UGANDA
TAZIKISTAN INDIA MAURITIUS VIETNAM UZBEKISTAN
MOLDOVA SOUTH AFRICA ALGERIA MYANMAR RUSSIA
Private Limited

Contact us
ADDRESS:
4024, A-WING, OBEROI GARDEN ESTATE,
CHANDIVALI ROAD, ANDHERI (E),MUMBAI - 400 072

+91-22-66884949 / 022-66884804

+91 – 9167770808

info@tuliplab.com

www.tuliplab.com